JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma

Clinical trial NCT07336823 · RECRUITING

Trial details

NCT number: NCT07336823
Sponsor: Shenzhen Genocury Biotech Co., Ltd.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2026-01-20
Primary completion: 2028-12-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.